Skip to content

Luke Evnin, Director at Werewolf Therapeutics, sold HOWL on Jun 29, 2026

Data as of Oct 16

▼ SELL$47.1K157,084 shares at $0.30Luke Evnin DirectorHOWL Werewolf Therapeutics, Inc.
Watch HOWL
Traded
Jun 29, 2026
Disclosed
Jun 29, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Luke Evnin, Director at Werewolf Therapeutics, sold HOWL on Jun 29, 2026TRADEDDISCLOSED
HOWLSimilar stocks (S&P 500 (SPY)), rebased to HOWL's price on the disclosure day
HOWL since disclosure
+218.2%
after the sale
Similar stocks (SPY) since disclosure
+3.0%
S&P 500 (SPY)

Change in closing price from Jun 29, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on HOWL →